Marek's Disease Vaccine is used to prevent Marek's disease in chickens, which is the three major diseases that endanger the healthy development of the chicken industry.
The global Marek's Disease Vaccine market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Marek's Disease Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Marek's Disease Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Marek's Disease Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key manufacturers of Marek's Disease Vaccine include Merck, Ceva, Zoetis, Boehringer Ingelheim, Guangdong Wen's Dahuanong Biotechnology Co., Ltd., Merial, Ruipu Biopharmaceutical Co., Ltd., Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. and Beijing Huadu Shihua Biological Products Co., Ltd., etc. In 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes:
This report presents an overview of global market for Marek's Disease Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Marek's Disease Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Marek's Disease Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Marek's Disease Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Marek's Disease Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Marek's Disease Vaccine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Merck, Ceva, Zoetis, Boehringer Ingelheim, Guangdong Wen's Dahuanong Biotechnology Co., Ltd., Merial, Ruipu Biopharmaceutical Co., Ltd., Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. and Beijing Huadu Shihua Biological Products Co., Ltd., etc.
By Company
Merck
Ceva
Zoetis
Boehringer Ingelheim
Guangdong Wen's Dahuanong Biotechnology Co., Ltd.
Merial
Ruipu Biopharmaceutical Co., Ltd.
Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
Beijing Huadu Shihua Biological Products Co., Ltd.
Guangxi Lichengdong Biological Co., Ltd.
Segment by Type
Bivalent Vaccine
Monovalent Vaccine
Segment by Application
Veterinary Pharmacy
Online Sale
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Marek's Disease Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Marek's Disease Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Marek's Disease Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Marek's Disease Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Marek's Disease Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Bivalent Vaccine
1.2.3 Monovalent Vaccine
1.3 Market by Application
1.3.1 Global Marek's Disease Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Veterinary Pharmacy
1.3.3 Online Sale
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Marek's Disease Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Marek's Disease Vaccine Revenue by Region
2.2.1 Global Marek's Disease Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Marek's Disease Vaccine Revenue by Region (2018-2023)
2.2.3 Global Marek's Disease Vaccine Revenue by Region (2024-2029)
2.2.4 Global Marek's Disease Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Marek's Disease Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Marek's Disease Vaccine Sales by Region
2.4.1 Global Marek's Disease Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Marek's Disease Vaccine Sales by Region (2018-2023)
2.4.3 Global Marek's Disease Vaccine Sales by Region (2024-2029)
2.4.4 Global Marek's Disease Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Marek's Disease Vaccine Sales by Manufacturers
3.1.1 Global Marek's Disease Vaccine Sales by Manufacturers (2018-2023)
3.1.2 Global Marek's Disease Vaccine Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Marek's Disease Vaccine in 2022
3.2 Global Marek's Disease Vaccine Revenue by Manufacturers
3.2.1 Global Marek's Disease Vaccine Revenue by Manufacturers (2018-2023)
3.2.2 Global Marek's Disease Vaccine Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Marek's Disease Vaccine Revenue in 2022
3.3 Global Key Players of Marek's Disease Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Marek's Disease Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Marek's Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Marek's Disease Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Marek's Disease Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Marek's Disease Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Marek's Disease Vaccine Sales by Type
4.1.1 Global Marek's Disease Vaccine Historical Sales by Type (2018-2023)
4.1.2 Global Marek's Disease Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Marek's Disease Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Marek's Disease Vaccine Revenue by Type
4.2.1 Global Marek's Disease Vaccine Historical Revenue by Type (2018-2023)
4.2.2 Global Marek's Disease Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Marek's Disease Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Marek's Disease Vaccine Price by Type
4.3.1 Global Marek's Disease Vaccine Price by Type (2018-2023)
4.3.2 Global Marek's Disease Vaccine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Marek's Disease Vaccine Sales by Application
5.1.1 Global Marek's Disease Vaccine Historical Sales by Application (2018-2023)
5.1.2 Global Marek's Disease Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Marek's Disease Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Marek's Disease Vaccine Revenue by Application
5.2.1 Global Marek's Disease Vaccine Historical Revenue by Application (2018-2023)
5.2.2 Global Marek's Disease Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Marek's Disease Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Marek's Disease Vaccine Price by Application
5.3.1 Global Marek's Disease Vaccine Price by Application (2018-2023)
5.3.2 Global Marek's Disease Vaccine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Marek's Disease Vaccine Market Size by Type
6.1.1 US & Canada Marek's Disease Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Marek's Disease Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Marek's Disease Vaccine Market Size by Application
6.2.1 US & Canada Marek's Disease Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Marek's Disease Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Marek's Disease Vaccine Market Size by Country
6.3.1 US & Canada Marek's Disease Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Marek's Disease Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Marek's Disease Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Marek's Disease Vaccine Market Size by Type
7.1.1 Europe Marek's Disease Vaccine Sales by Type (2018-2029)
7.1.2 Europe Marek's Disease Vaccine Revenue by Type (2018-2029)
7.2 Europe Marek's Disease Vaccine Market Size by Application
7.2.1 Europe Marek's Disease Vaccine Sales by Application (2018-2029)
7.2.2 Europe Marek's Disease Vaccine Revenue by Application (2018-2029)
7.3 Europe Marek's Disease Vaccine Market Size by Country
7.3.1 Europe Marek's Disease Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Marek's Disease Vaccine Sales by Country (2018-2029)
7.3.3 Europe Marek's Disease Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Marek's Disease Vaccine Market Size
8.1.1 China Marek's Disease Vaccine Sales (2018-2029)
8.1.2 China Marek's Disease Vaccine Revenue (2018-2029)
8.2 China Marek's Disease Vaccine Market Size by Application
8.2.1 China Marek's Disease Vaccine Sales by Application (2018-2029)
8.2.2 China Marek's Disease Vaccine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Marek's Disease Vaccine Market Size by Type
9.1.1 Asia Marek's Disease Vaccine Sales by Type (2018-2029)
9.1.2 Asia Marek's Disease Vaccine Revenue by Type (2018-2029)
9.2 Asia Marek's Disease Vaccine Market Size by Application
9.2.1 Asia Marek's Disease Vaccine Sales by Application (2018-2029)
9.2.2 Asia Marek's Disease Vaccine Revenue by Application (2018-2029)
9.3 Asia Marek's Disease Vaccine Sales by Region
9.3.1 Asia Marek's Disease Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Marek's Disease Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Marek's Disease Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Marek's Disease Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Marek's Disease Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Marek's Disease Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Marek's Disease Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Marek's Disease Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Marek's Disease Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Marek's Disease Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Marek's Disease Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Marek's Disease Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Marek's Disease Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Merck Marek's Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Ceva
11.2.1 Ceva Company Information
11.2.2 Ceva Overview
11.2.3 Ceva Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Ceva Marek's Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Ceva Recent Developments
11.3 Zoetis
11.3.1 Zoetis Company Information
11.3.2 Zoetis Overview
11.3.3 Zoetis Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Zoetis Marek's Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Zoetis Recent Developments
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Information
11.4.2 Boehringer Ingelheim Overview
11.4.3 Boehringer Ingelheim Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Boehringer Ingelheim Marek's Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Boehringer Ingelheim Recent Developments
11.5 Guangdong Wen's Dahuanong Biotechnology Co., Ltd.
11.5.1 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Company Information
11.5.2 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Overview
11.5.3 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Recent Developments
11.6 Merial
11.6.1 Merial Company Information
11.6.2 Merial Overview
11.6.3 Merial Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Merial Marek's Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Merial Recent Developments
11.7 Ruipu Biopharmaceutical Co., Ltd.
11.7.1 Ruipu Biopharmaceutical Co., Ltd. Company Information
11.7.2 Ruipu Biopharmaceutical Co., Ltd. Overview
11.7.3 Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Ruipu Biopharmaceutical Co., Ltd. Recent Developments
11.8 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
11.8.1 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Company Information
11.8.2 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Overview
11.8.3 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Developments
11.9 Beijing Huadu Shihua Biological Products Co., Ltd.
11.9.1 Beijing Huadu Shihua Biological Products Co., Ltd. Company Information
11.9.2 Beijing Huadu Shihua Biological Products Co., Ltd. Overview
11.9.3 Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Beijing Huadu Shihua Biological Products Co., Ltd. Recent Developments
11.10 Guangxi Lichengdong Biological Co., Ltd.
11.10.1 Guangxi Lichengdong Biological Co., Ltd. Company Information
11.10.2 Guangxi Lichengdong Biological Co., Ltd. Overview
11.10.3 Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Guangxi Lichengdong Biological Co., Ltd. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Marek's Disease Vaccine Industry Chain Analysis
12.2 Marek's Disease Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Marek's Disease Vaccine Production Mode & Process
12.4 Marek's Disease Vaccine Sales and Marketing
12.4.1 Marek's Disease Vaccine Sales Channels
12.4.2 Marek's Disease Vaccine Distributors
12.5 Marek's Disease Vaccine Customers
13 Market Dynamics
13.1 Marek's Disease Vaccine Industry Trends
13.2 Marek's Disease Vaccine Market Drivers
13.3 Marek's Disease Vaccine Market Challenges
13.4 Marek's Disease Vaccine Market Restraints
14 Key Findings in The Global Marek's Disease Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Merck
Ceva
Zoetis
Boehringer Ingelheim
Guangdong Wen's Dahuanong Biotechnology Co., Ltd.
Merial
Ruipu Biopharmaceutical Co., Ltd.
Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
Beijing Huadu Shihua Biological Products Co., Ltd.
Guangxi Lichengdong Biological Co., Ltd.
*If Applicable.